Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors

Name: Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors
SKU: 3067
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 4 Articles Tags: acetylcholine, dopamine, elliott-richelson, histamine, norepinephrine, serotonin

Description

Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors

Description

Elliott Richelson, MD

GENERAL PSYCHOPHARMACOLOGY

The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors

Elliott Richelson, MD

In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders

Duloxetine in Military Posttraumatic Stress Disorder

Can We Distinguish Anxiety From Depression?

Paolo Castrogiovanni, MD: Can Serotonin and Fluoxetine Levels in Plasma and Platelets Predict Clinical Response in Depression?

Elliott Richelson, MD: The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors

Description

Elliott Richelson, MD

GENERAL PSYCHOPHARMACOLOGY

The Clinical Relevance of Antidepressant Interaction With Neurotransmitter Transporters and Receptors

Elliott Richelson, MD

Related products

In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders

Duloxetine in Military Posttraumatic Stress Disorder

Can We Distinguish Anxiety From Depression?

Paolo Castrogiovanni, MD: Can Serotonin and Fluoxetine Levels in Plasma and Platelets Predict Clinical Response in Depression?